MedPath

Cerebrolysin

Generic Name
Cerebrolysin
Drug Type
Biotech
CAS Number
12656-61-0
Unique Ingredient Identifier
37KZM6S21G

Overview

No overview information available.

Background

No background information available.

Indication

用于脑血管疾病及脑动脉硬化、脑外伤或脑卒中后遗症、大脑发育不全、老年性痴呆以及记忆力减退者。

Associated Conditions

  • Alzheimer's Disease (AD)
  • Cerebrovascular Diseases
  • Craniocerebral Injuries
  • Stroke

Clinical Trials

Early Phase 1
Not yet recruiting
Posted: 2024/07/08
Sponsor:
University Hospital ...
Early Phase 1
Not yet recruiting
Posted: 2024/04/01
Sponsor:
Chang Gung Memorial ...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath